Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Bay Area Reporter - September 28, 2006
Bob Roehr
Senator Mike Enzi (R-Wyoming), chairman of the Health, Education, Labor, and Pensions Committee, tried to move the bill, which had been developed through an arduous series of bipartisan, bicameral meetings between congressional staffers and AIDS advocates.
But Senator Mark Dayton (D-Minnesota) objected on behalf of Democratic senators opposed to the legislation because their states would lose funding. That group includes New Yorkers Hillary Rodham Clinton and Charles Schumer, Californians Dianne Feinstein and Barbara Boxer, and Bob Menendez and Frank Lautenberg from New Jersey. They have proposed extending the current funding formula for one year while negotiations continue.
"I'm sorry to hear the objection," Enzi responded. "If they truly have the HIV numbers they will get the money. If the don't have the HIV numbers, yes, they will lose the money."
The opposition was undercut by Massachusetts Senator Ted Kennedy, the ranking Democratic member of the committee, who has played a leading role in crafting the legislation. In a statement released later that evening Kennedy said, "There are few more urgent responsibilities for Congress this week than to pass this bipartisan legislation."
Reaction for gay Republicans was swift.
"Senator Clinton and her five Democratic colleagues should stop playing politics with this life-saving program," said Patrick Sammon, Log Cabin Republicans executive vice president. "Failure to pass this law by October 1 will have a devastating impact on tens of thousands of people with HIV/AIDS."
Enzi and Kennedy are considering other options to passing Ryan White. The most likely one is attaching it as an amendment to another piece of legislation, perhaps the spending bill for the Department of Defense.
Last week, the House Energy and Commerce Committee resolved some of the contentious issues in Ryan White, which it passed 38-10 on September 20.
Some AIDS advocacy organizations support that bill. The AIDS Foundation of Chicago's David Munar called it "a vast improvement over the proposal submitted last year by the Bush administration."
He singled out modifications to how coded data of HIV cases are counted toward the distribution of funds as a significant change. He also saw insufficient funds as the root of most of the problems and called for increased spending.
Other advocates remain unhappy, primarily because their jurisdictions are likely to see reduced funding. Hardest hit would be San Francisco, which receives about $28 million a year under the current Ryan White structure. If the new language becomes law, the city would face immediate cuts but the big hit, an estimated $10.4 million, would come in four years, according to Ernest Hopkins, a lobbyist for the San Francisco AIDS Foundation.
New York will lose $17.8 million in Title I funding in the first years, and $78 million over four years in Title II funding, according to estimates by the New York Department of Health and Mental Hygiene.
Clinton's opposition is longstanding; she was the only senator to vote against the measure in committee. Late Friday afternoon, September 22, California's Democratic senators joined her in opposition.
"California HIV/AIDS projects take a big financial hit under the current version of the Ryan White reauthorization bill. Without the opportunity to offer amendments, there is a serious risk that established programs in San Francisco and across the state will be unable to preserve the quality of care they provide to HIV/AIDS patients," Feinstein said.
Boxer added, "If the Bush administration would put adequate resources into the fight against HIV/AIDS, we wouldn't be having this argument about a formula. It's unacceptable that California, and therefore our HIV/AIDS patients, will suffer if we don't go along with every detail of this bill."
The formula that Boxer criticized was the result of bipartisan congressional negotiations led by Kennedy.
060928
BR060915
Copyright © 2006 - The Bay Area Reporter. Reproduction of this article (other than one copy for personal reference) must be cleared through the The Bay Area Reporter.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .